<?xml version="1.0" encoding="UTF-8"?>
<p>The year 2020 is the designated date for achieving the Joint United Nations Programme on HIV/AIDS 90‐90‐90 targets for human immunodeficiency virus (HIV) diagnosis, treatment and viral suppression [
 <xref rid="jia2sup25525-bib-0001" ref-type="ref">1</xref>]; it also marks completion of one‐third of the time allotted (from 2015 to 2030) for achieving the Sustainable Development Goals and the corresponding end of acquired immune deficiency syndrome (AIDS) [
 <xref rid="jia2sup25525-bib-0002" ref-type="ref">2</xref>]. Yet the HIV epidemic is far from ended: nearly two million people still acquire HIV infection every year, the number of people living with HIV (PLHIV) continues to increase and new infections are still on the rise in many populations [
 <xref rid="jia2sup25525-bib-0003" ref-type="ref">3</xref>]. To date, the response to HIV has largely been an “exceptional” one, with dedicated funders (most notably the President’s Emergency Plan for AIDS Relief) tending to build new structures rather than strengthening the underlying health systems [
 <xref rid="jia2sup25525-bib-0004" ref-type="ref">4</xref>]. By some measures, this approach has been exceedingly successful, resulting in over 21 million people receiving antiretroviral therapy (ART) and a corresponding reduction in AIDS mortality [
 <xref rid="jia2sup25525-bib-0003" ref-type="ref">3</xref>]. But it is also an approach that may require modification in the coming decade, with progress towards Sustainable Development Goals underway and a concomitant focus on Universal Health Coverage (UHC) emerging [
 <xref rid="jia2sup25525-bib-0005" ref-type="ref">5</xref>].
</p>
